Swedbank AB Boosts Stock Position in Corteva, Inc. $CTVA

Swedbank AB increased its stake in Corteva, Inc. (NYSE:CTVA) by 142.9% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,898,735 shares of the company’s stock after buying an additional 1,117,021 shares during the period. Swedbank AB’s holdings in Corteva were worth $127,272,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Brighton Jones LLC lifted its position in Corteva by 307.2% during the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after purchasing an additional 11,760 shares in the last quarter. Woodline Partners LP increased its holdings in shares of Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after purchasing an additional 16,644 shares during the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Corteva by 62.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock worth $191,000 after purchasing an additional 980 shares during the last quarter. Cresset Asset Management LLC increased its holdings in shares of Corteva by 2.6% in the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after purchasing an additional 181 shares during the last quarter. Finally, Jump Financial LLC bought a new stake in shares of Corteva in the second quarter worth about $1,464,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Up 0.7%

Shares of NYSE CTVA opened at $79.57 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The firm has a market capitalization of $53.22 billion, a price-to-earnings ratio of 46.81, a PEG ratio of 2.43 and a beta of 0.59. The stock has a 50 day moving average price of $81.33 and a 200 day moving average price of $73.96. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.63.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.Corteva’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be issued a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is presently 42.35%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CTVA. Wall Street Zen cut Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. The Goldman Sachs Group lifted their target price on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Tuesday, April 14th. Oppenheimer lifted their target price on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Zacks Research cut Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Finally, Mizuho lifted their target price on Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. Thirteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $88.14.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.